Unknown

Dataset Information

0

Overcoming Insulin Insufficiency by Forced Follistatin Expression in ?-cells of db/db Mice.

ABSTRACT: Diabetes poses a substantial burden to society as it can lead to serious complications and premature death. The number of cases continues to increase worldwide. Two major causes of diabetes are insulin resistance and insulin insufficiency. Currently, there are few antidiabetic drugs available that can preserve or protect ?-cell function to overcome insulin insufficiency in diabetes. We describe a therapeutic strategy to preserve ?-cell function by overexpression of follistatin (FST) using an AAV vector (AAV8-Ins-FST) in diabetic mouse model. Overexpression of FST in the pancreas of db/db mouse increased ?-cell islet mass, decreased fasting glucose level, alleviated diabetic symptoms, and essentially doubled lifespan of the treated mice. The observed islet enlargement was attributed to ?-cell proliferation as a result of bioneutralization of myostatin and activin by FST. Overall, our study indicates overexpression of FST in the diabetic pancreas preserves ?-cell function by promoting ?-cell proliferation, opening up a new therapeutic avenue for the treatment of diabetes.

SUBMITTER: Zhao C 

PROVIDER: S-EPMC4427879 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Overcoming Insulin Insufficiency by Forced Follistatin Expression in β-cells of db/db Mice.

Zhao Chunxia C   Qiao Chunping C   Tang Ru-Hang RH   Jiang Jiangang J   Li Jianbin J   Martin Carrie Bette CB   Bulaklak Karen K   Li Juan J   Wang Dao Wen DW   Xiao Xiao X  

Molecular therapy : the journal of the American Society of Gene Therapy 20150213 5

Diabetes poses a substantial burden to society as it can lead to serious complications and premature death. The number of cases continues to increase worldwide. Two major causes of diabetes are insulin resistance and insulin insufficiency. Currently, there are few antidiabetic drugs available that can preserve or protect β-cell function to overcome insulin insufficiency in diabetes. We describe a therapeutic strategy to preserve β-cell function by overexpression of follistatin (FST) using an AAV  ...[more]

Similar Datasets

Unknown Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice.
| S-EPMC2844847 | biostudies-other
Unknown Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes.
| S-EPMC2889771 | biostudies-literature
Unknown Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance.
| S-EPMC3577828 | biostudies-literature
Unknown Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice.
| S-EPMC2889760 | biostudies-literature
Unknown Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice.
| S-EPMC7934061 | biostudies-literature
Unknown Oral treatment with <i>Eubacterium hallii</i> improves insulin sensitivity in <i>db/db</i> mice.
| S-EPMC5515273 | biostudies-literature
Unknown Celastrol, an NF-?B inhibitor, improves insulin resistance and attenuates renal injury in db/db mice.
| S-EPMC3637455 | biostudies-literature
Unknown Improved Glucose-Stimulated Insulin Secretion by Selective Intraislet Inhibition of Angiotensin II Type 1 Receptor Expression in Isolated Islets of db/db Mice.
| S-EPMC3859026 | biostudies-literature
Unknown Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.
| S-EPMC2494684 | biostudies-literature
Unknown Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
| S-EPMC5885408 | biostudies-literature